comprehensive -WSS

comprehensive

author：focus 2025-09-30 21:57:38 - browse：259

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

leisure time

WSS

Sanofi CEO defends move to abandon profit guidance, boost research

Addiction doctors spar with methadone clinics over legislation

FDA approves potent Eli Lilly obesity drug, Zepbound

Health insurers say they are turning to AI to cut costs, improve care

Do more moles mean more problems? Not so, says new study

Ambulance rides for just $100? Advisers want major billing fixes

focus

comprehensive

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Startling documents reveal new facets of Sacklers' opioid empire

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Extreme heat events are a public health emergency

Apple is now the first public company to be valued at $3 trillion

Prosthetic arm enables patients to feel the objects they grip

Bright Health sells Medicare Advantage business to Molina

Heat waves linked to early deliveries, preterm births in new study

Hepatitis C has a cure — but many Americans still lack access to it

Ambulance rides for just $100? Advisers want major billing fixes

explore

Sanofi CEO defends move to abandon profit guidance, boost research

Startling documents reveal new facets of Sacklers' opioid empire

Insmed lung disease drug hits target in key Phase 3 trial

Medicare will require more price transparency from hospitals

FDA approves Recor Medical high blood pressure device

Medicare solvency divides Republicans at the presidential debate

leisure time

Wikipedia

leisure time

hotspot